Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Irritable Bowel Syndrome

Free Subscription Articles published in Gastroenterology Retrieve available abstracts of 54 articles: HTML format

Single Articles

February 2026
1. DI LORENZO C, Saps M, Chumpitazi BP, Rajindrajith S, et al
   Lower and Biliary Disorders of Gut-Brain Interaction: Child/Adolescent.
   Gastroenterology. 2026 Feb 17:S0016-5085(26)00125.
   PubMed     Abstract available
   
   
   
2. CORSETTI M, Shin A, Lacy BE, Cash BD, et al
   BOWEL DISORDERS.
   Gastroenterology. 2026 Feb 17:S0016-5085(26)00132.
   PubMed     Abstract available
   
   
   
3. ROUTHIAUX K, Balsiger LM, Ceulemans M, Vanuytsel T, et al
   Involvement of Eosinophil-Driven Intestinal Immune Activation in Different Irritable Bowel Syndrome Subtypes and in the Response to a FODMAP Lowering Diet: A Post Hoc Analysis of the Randomized Controlled DOMINO Trial.
   Gastroenterology. 2026 Feb 11:S0016-5085(25)06149.
   PubMed    
   
   
   January 2026
4. SJOLUND J, Hreinsson JP, Bergstrom A, Tornblom H, et al
   Adolescent Risk Factors for the Presence and Persistence of Irritable Bowel Syndrome in Young Adulthood-Findings From a Prospective Birth Cohort.
   Gastroenterology. 2026 Jan 30:S0016-5085(26)00033.
   PubMed    
   
   
   
5. KESZTHELYI D
   "The cure better not worse than the illness" - lessons from ethosuximide in irritable bowel syndrome.
   Gastroenterology. 2026 Jan 29:S0016-5085(26)00087.
   PubMed    
   
   
   December 2025
6. LIN S, Shen P, Wan Y, Wang C, et al
   Methodological Comments on "Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION)" Study.
   Gastroenterology. 2025 Dec 4:S0016-5085(25)06592.
   PubMed    
   
   
   
7. ZHANG M
   Comment on "Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION): A Multicenter Randomized Controlled Trial".
   Gastroenterology. 2025 Dec 4:S0016-5085(25)06593.
   PubMed    
   
   
   November 2025
8. BHARUCHA AE, Knowles CH, Malcolm A
   An Evidence-Based Practical Review on Common Benign Anorectal Disorders: Hemorrhoids, Anal Fissure, Dyssynergic Defecation, and Fecal Incontinence.
   Gastroenterology. 2025 Nov 14:S0016-5085(25)05798.
   PubMed     Abstract available
   
   
   October 2025
9. LONG Q
   Analysis of "Mebeverine and the Influence of Labeling in Adolescents With Irritable Bowel Syndrome or Functional Abdominal Pain Not Otherwise Specified: A 2 x 2 Randomized, Placebo-Controlled Trial".
   Gastroenterology. 2025 Oct 18:S0016-5085(25)05890.
   PubMed    
   
   
   August 2025
10. FLACK R, Brownlow G, Burton-Murray H, Palsson O, et al
    The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder (ARFID) Symptoms in Adults with Disorders of Gut-Brain Interaction: A Population-Based Study.
    Gastroenterology. 2025 Aug 20:S0016-5085(25)05896.
    PubMed     Abstract available
    
    
    July 2025
11. GAO J, Lee AA, Abtahi S, Turner JR, et al
    Low FODMAP diet improves colonic barrier function and mast cell activation in patients with IBS-D: A mechanistic trial.
    Gastroenterology. 2025 Jul 18:S0016-5085(25)05771.
    PubMed     Abstract available
    
    
    May 2025
12. YANG JW, Qi LY, Yan SY, She YF, et al
    Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION): a multi-centre randomized controlled trial.
    Gastroenterology. 2025 May 27:S0016-5085(25)00826.
    PubMed     Abstract available
    
    
    April 2025
13. LAMICHHANE R, Gautam M, Fletcher JG, Bailey KR, et al
    Inadequate Propulsion and Pelvic Floor Relaxation in Dyssynergic Defecation: Insights from Synchronous Proctomanometry.
    Gastroenterology. 2025 Apr 30:S0016-5085(25)00651.
    PubMed     Abstract available
    
    
    March 2025
14. REXWINKEL R, Vermeijden NK, Zeevenhooven J, Kelder J, et al
    Mebeverine and the influence of labeling in adolescents with irritable bowel syndrome or functional abdominal pain-NOS: a 2x2 randomized, placebo-controlled trial.
    Gastroenterology. 2025 Mar 10:S0016-5085(25)00493.
    PubMed     Abstract available
    
    
    February 2025
15. AGUILERA-LIZARRAGA J, Lopez-Lopez C, Jaramillo-Polanco J, Florens MV, et al
    Psychological stress-induced local immune response to food antigens increases pain signaling across the gut in mice.
    Gastroenterology. 2025 Feb 18:S0016-5085(25)00371.
    PubMed     Abstract available
    
    
    
16. TORICES L, Bonfiglio F, Esteban-Blanco C, Zamfir-Taranu A, et al
    Domain-specific effects of sucrase-isomaltase genotype in irritable bowel syndrome.
    Gastroenterology. 2025 Feb 11:S0016-5085(25)00362.
    PubMed    
    
    
    January 2025
17. SINGH P, Chey WD, Takakura W, Cash BD, et al
    A novel, IBS-specific IgG ELISA-based elimination diet in irritable bowel syndrome: A randomized, sham-controlled trial.
    Gastroenterology. 2025 Jan 31:S0016-5085(25)00328.
    PubMed     Abstract available
    
    
    
18. HUNG KW, Leiman DA, Kaza A, Watson R, et al
    AGA Institute Quality Indicator Development for Irritable Bowel Syndrome.
    Gastroenterology. 2025 Jan 15:S0016-5085(24)05666.
    PubMed    
    
    
    December 2024
19. HUANG C, Zhong Y, He B, Shao X, et al
    Analysis of "Prevotella Is Associated With Sex-Based Differences in Irritable Bowel Syndrome".
    Gastroenterology. 2024 Dec 24:S0016-5085(24)05799.
    PubMed    
    
    
    
20. ZHENG Q, Zhou Y, Tian J
    Optimizing Methodological Rigor and Evidence Reporting in Brain-Gut Behavioral Treatments for Irritable Bowel Syndrome: Enhancing the Credibility of Network Meta-Analyses.
    Gastroenterology. 2024 Dec 7:S0016-5085(24)05780.
    PubMed    
    
    
    
21. ZHANG L, Li J, Li Y
    Comment on "Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis".
    Gastroenterology. 2024 Dec 5:S0016-5085(24)05781.
    PubMed    
    
    
    September 2024
22. GROVER M, Vanuytsel T, Chang L
    Intestinal permeability in disorders of gut-brain interaction (DGBI): From bench to bedside.
    Gastroenterology. 2024 Sep 3:S0016-5085(24)05416.
    PubMed     Abstract available
    
    
    July 2024
23. BARBARO MR, Cremon C, Marasco G, Savarino E, et al
    Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome.
    Gastroenterology. 2024 Jul 12:S0016-5085(24)05204.
    PubMed     Abstract available
    
    
    
24. DONG TS, Peters K, Gupta A, Jacobs JP, et al
    Prevotella Is Associated with Sex-Based Differences in Irritable Bowel Syndrome.
    Gastroenterology. 2024 Jul 12:S0016-5085(24)05209.
    PubMed    
    
    
    June 2024
25. BOOTSMA E, Jansen L, van Houte K, Kessler RC, et al
    Beyond the Norm: epidemiology of irritable bowel syndrome and mental health among sexual and gender-diverse young adults in a large representative cohort.
    Gastroenterology. 2024 Jun 27:S0016-5085(24)05121.
    PubMed    
    
    
    
26. ARONIADIS O, Keefer L
    Deconstructing the "Pain" Points When Considering the Impact of Brain-Gut Behavior Therapies on Irritable Bowel Syndrome.
    Gastroenterology. 2024 Jun 25:S0016-5085(24)05114.
    PubMed    
    
    
    
27. JANDL B, Dighe S, Baumgartner M, Makristathis A, et al
    Gastrointestinal biofilms - Endoscopic detection, disease relevance and therapeutic strategies.
    Gastroenterology. 2024 Jun 12:S0016-5085(24)05054.
    PubMed     Abstract available
    
    
    May 2024
28. GOODOORY VC, Khasawneh M, Thakur ER, Everitt HA, et al
    Effect of Brain-gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-analysis.
    Gastroenterology. 2024 May 20:S0016-5085(24)04932.
    PubMed     Abstract available
    
    
    March 2024
29. KHASAWNEH M, Black CJ, Ford AC
    Efficacy of Drugs Acting on Histamine-1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
    Gastroenterology. 2024 Mar 16:S0016-5085(24)00297.
    PubMed    
    
    
    
30. ZINGONE F, Bai JC, Cellier C, Ludvigsson JF, et al
    Celiac disease-related conditions: Who to test?
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00282.
    PubMed     Abstract available
    
    
    
31. PEERY AF, Kelly CR, Kao D, Vaughn BP, et al
    AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
    Gastroenterology. 2024;166:409-434.
    PubMed     Abstract available
    
    
    February 2024
32. VAN DEN HOUTE K, Colomier E, Routhiaux K, Marien Z, et al
    Efficacy and findings of a blinded randomized reintroduction phase for the low FODMAP diet in Irritable Bowel Syndrome.
    Gastroenterology. 2024 Feb 22:S0016-5085(24)00170.
    PubMed     Abstract available
    
    
    
33. FORD AC, Vanner S, Kashyap PC, Nasser Y, et al
    CHRONIC VISCERAL PAIN: NEW PERIPHERAL MECHANISTIC INSIGHTS AND RESULTING TREATMENTS.
    Gastroenterology. 2024 Feb 5:S0016-5085(24)00132.
    PubMed     Abstract available
    
    
    
34. TACK J, Carbone F, Chang L, Lacy BE, et al
    Patient reported outcomes in Disorders of Gut-Brain Interaction.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00124.
    PubMed     Abstract available
    
    
    December 2023
35. SHIHA MG, Aziz I
    Amitriptyline for the management of IBS in primary care.
    Gastroenterology. 2023 Dec 24:S0016-5085(23)05680.
    PubMed     Abstract available
    
    
    
36. SO SY, Badu S, Wu Q, Yalcinkaya N, et al
    Sex-dependent efficacy of dietary fiber in pediatric functional abdominal pain.
    Gastroenterology. 2023 Dec 18:S0016-5085(23)05607.
    PubMed     Abstract available
    
    
    
37. SEHGAL K, Yadav D, Saha S, Mara K, et al
    Sex-Discordant Fecal Microbiota Transplantation for C. difficile may increase risk of post-infection irritable bowel syndrome.
    Gastroenterology. 2023 Dec 4:S0016-5085(23)05570.
    PubMed    
    
    
    November 2023
38. GARG P, Garg PK, Bhattacharya K
    Psyllium husk positively alters gut microbiota, decreases inflammation and has bowel-regulatory action, paving way for physiological management of irritable bowel syndrome (IBS).
    Gastroenterology. 2023 Nov 16:S0016-5085(23)05241.
    PubMed    
    
    
    August 2023
39. ALMARIO CV, Sharabi E, Chey WD, Lauzon M, et al
    Prevalence and Burden of Illness of Rome IV Irritable Bowel Syndrome in the United States: Results from a Nationwide Cross-Sectional Study.
    Gastroenterology. 2023 Aug 16:S0016-5085(23)04889.
    PubMed     Abstract available
    
    
    
40. GOODOORY VC, Khasawneh M, Black CJ, Quigley EM, et al
    Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
    Gastroenterology. 2023 Aug 2:S0016-5085(23)04838.
    PubMed     Abstract available
    
    
    June 2023
41. BALLOU S, Singh P, Nee J, Rangan V, et al
    Prevalence and Associated Factors of Bloating: Results from the Rome Foundation Global Epidemiology Study.
    Gastroenterology. 2023 Jun 12:S0016-5085(23)00826.
    PubMed     Abstract available
    
    
    
42. HREINSSON JP, Tornblom H, Tack J, Drossman DA, et al
    Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups.
    Gastroenterology. 2023;164:1211-1222.
    PubMed     Abstract available
    
    
    February 2023
43. FOGELSON KA, Dorrestein PC, Zarrinpar A, Knight R, et al
    The Gut Microbial Bile Acid Modulation and its Relevance to Digestive Health and Diseases.
    Gastroenterology. 2023 Feb 23:S0016-5085(23)00161.
    PubMed     Abstract available
    
    
    January 2023
44. ZHOU Q, Yang L, Verne ML, Zhang BB, et al
    Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric COMT/miR-155/TNF-alpha Axis.
    Gastroenterology. 2023 Jan 6:S0016-5085(23)00008.
    PubMed     Abstract available
    
    
    October 2022
45. CAMILLERI M, Dilmaghani S
    Treatment of Irritable Bowel Syndrome Using Fecal Microbiota Transplantation: A Step Forward?
    Gastroenterology. 2022;163:815-817.
    PubMed    
    
    
    September 2022
46. KESZTHELYI D
    Histamine-producing bacteria: the missing link in irritable bowel syndrome?
    Gastroenterology. 2022 Sep 8. pii: S0016-5085(22)01038.
    PubMed    
    
    
    August 2022
47. GRABAUSKAS G, Gao J, Wu X, Zhou SY, et al
    Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells.
    Gastroenterology. 2022 Aug 4. pii: S0016-5085(22)00829.
    PubMed     Abstract available
    
    
    July 2022
48. LEMBO A, Sultan S, Chang L, Heidelbaugh JJ, et al
    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
    Gastroenterology. 2022;163:137-151.
    PubMed     Abstract available
    
    
    
49. CHANG L, Sultan S, Lembo A, Verne GN, et al
    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
    Gastroenterology. 2022;163:118-136.
    PubMed     Abstract available
    
    
    June 2022
50. ZIA JK, Lenhart A, Yang PL, Heitkemper MM, et al
    Risk Factors for Abdominal Pain Disorders of Gut Brain Interaction in Adults and Children: A Systematic Review.
    Gastroenterology. 2022 Jun 15. pii: S0016-5085(22)00646.
    PubMed     Abstract available
    
    
    
51. EL-SALHY M, Winkel R, Casen C, Hausken T, et al
    Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at three years after transplantation.
    Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00625.
    PubMed     Abstract available
    
    
    April 2022
52. BUSHYHEAD D, Quigley EMM
    Small Intestinal Bacterial Overgrowth, Pathophysiology and its implications for Definition and Management.
    Gastroenterology. 2022 Apr 7. pii: S0016-5085(22)00357.
    PubMed     Abstract available
    
    
    
53. AHUJA A
    Minority Patients With Irritable Bowel Syndrome Receive More Gastroenterology-Related Procedures Than White Counterparts: Nuances in Disparities Research.
    Gastroenterology. 2022;162:1354-1355.
    PubMed    
    
    
    March 2022
54. CHEY WD, Hashash JG, Manning L, Chang L, et al
    AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
    Gastroenterology. 2022 Mar 22. pii: S0016-5085(21)04084.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum